Vous êtes ici : Accueil > CD49d expression as a promising biomarker to monitor natalizumab efficacy

publications-2011-2015

CD49d expression as a promising biomarker to monitor natalizumab efficacy

Publié le 19 mars 2015
CD49d expression as a promising biomarker to monitor natalizumab efficacy
Auteurs
Defer G, Mariotte D, Derache N, Toutirais O, Legros H, Cauquelin B, Le Mauff B
Revue
InstitutI2BM
Année2 012

Retour à la liste